Vycor Medical (VYCO) Equity Average (2011 - 2026)

Vycor Medical (VYCO) has 16 years of Equity Average data on file, last reported at -$4.2 million in Q1 2026.

• Equity Average for Q1 2026 came in at -$4.2 million, down 9.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.2 million (down 9.69% YoY), and the FY2025 annual result was -$3.9 million, down 10.85% from the prior year.
• Equity Average slipped to -$4.2 million in Q1 2026 per VYCO's latest filing, from -$4.1 million in the prior quarter.
• Over five years, Equity Average peaked at -$95600.0 in Q1 2022 and troughed at -$4.2 million in Q1 2026.
• A 5-year average of -$3.2 million and a median of -$3.4 million in 2024 frame the typical range for Equity Average.
• On a YoY basis, Equity Average climbed as much as 95.5% in 2022 and fell as far as 4363.82% in 2022.
• A 5-year view of Equity Average shows it stood at -$2.9 million in 2022, then decreased by 13.85% to -$3.3 million in 2023, then slipped by 12.44% to -$3.7 million in 2024, then fell by 10.0% to -$4.1 million in 2025, then fell by 2.52% to -$4.2 million in 2026.
• Business Quant data shows VYCO's Equity Average at -$4.2 million in Q1 2026, -$4.1 million in Q4 2025, and -$3.9 million in Q3 2025.